10 employees
Epitopea is a transatlantic cancer immunotherapeutics company.
2021
$13M
from 4 investors over 4 rounds
Epitopea raised $13M on April 25, 2022
Investors: Novateur Ventures Inc., Advent Life Sciences, Cambridge Innovation Capital plc and Harrington Discovery Institute at University Hospitals